Next PMDA Consultation after Review of CardiAMP HF Trial DataSUNNYVALE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the ...
The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...
Hepatic ischemia-reperfusion injury (HIRI) is a key factor leading to complications and poor prognosis after hepatobiliary surgery, but its pathogenesis remains unclear. Hence, it is a very necessary ...